A Drug-Drug Interaction Study of Orforglipron (LY3502970) in Healthy Overweight and Obese Participants

NCT06186622 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy
Obese
Overweight

Interventions

DRUG: Orforglipron
DRUG: Simvastatin
DRUG: Digoxin
DRUG: Rosuvastatin
DRUG: Acetaminophen
DRUG: Midazolam
DRUG: Sodium Bicarbonate

Sponsor

Eli Lilly and Company